| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/28/2013 | EP2630158A2 Discovery of regulatory t cells programmed to suppress an immune response |
| 08/28/2013 | EP2630157A1 1-deoxy-d-xylulose 5-phosphate synthase alleles responsible for enhanced terpene biosynthesis |
| 08/28/2013 | EP2630156A1 Lactococcus crispr-cas sequences |
| 08/28/2013 | EP2630155A2 Novel hemagglutinin 5 (h5) proteins for the treatment and prevention of influenza infections |
| 08/28/2013 | EP2629797A2 Peptides for modulating t-cell activity and uses thereof |
| 08/28/2013 | EP2629794A1 Herpesvirus of turkeys vectored vaccine against avian influenza in poultry |
| 08/28/2013 | EP2629785A1 Short peptides for enhancing muscle function |
| 08/28/2013 | EP2629783A2 Retargeting of rat parvovirus h-1pv to cancer cells through genetic engineering of its capsid |
| 08/28/2013 | EP2157192B1 Compositions for diagnosis and therapy of diseases associated with aberrant expression of futrins (R-Spondins) |
| 08/28/2013 | CN103270161A Method for producing apolipoprotein in plants |
| 08/28/2013 | CN103270157A Human il-17-producing helper t cell detection marker and human il-7-producing helper t cell detection method |
| 08/28/2013 | CN103270156A Wdhd1 peptides and vaccines including the same |
| 08/28/2013 | CN103270049A Spider silk fusion protein structures for binding to an organic target |
| 08/28/2013 | CN103270048A New adjuvant |
| 08/28/2013 | CN103270047A Oprf/i agents and their use in hospitalized and other patients |
| 08/28/2013 | CN103270046A Methods and compositions for treating hemophilia B |
| 08/28/2013 | CN103269762A Affinity chromatography matrix |
| 08/28/2013 | CN103269761A Affinity chromatography matrix |
| 08/28/2013 | CN103269714A Newcastle disease virus vectored herpesvirus vaccines |
| 08/28/2013 | CN103269713A Antigen delivery platforms |
| 08/28/2013 | CN103266125A Preparation method of diphtheria toxin mutant CRM197 |
| 08/28/2013 | CN103266116A Cotton verticillium wilt disease resistance-related gene GaVdr1 and application thereof |
| 08/28/2013 | CN103266115A Corn stress-inducible gene ZmPsaH and encoding protein as well as application thereof |
| 08/28/2013 | CN103266069A Bacillus thuringiensis strain and application thereof |
| 08/28/2013 | CN103265632A Method for obtaining polyclonal antibody of sheep-ras-related and estrogen-regulated growth inhibitor |
| 08/28/2013 | CN103265630A Method for preparing exenatide |
| 08/28/2013 | CN103265629A Novel solid phase synthesis process for preparing thymalfasin |
| 08/28/2013 | CN103265628A Antibacterial peptide of heterometrus spinifer and application of antibacterial peptide |
| 08/28/2013 | CN103265627A HPV16L1-g protein and coding gene and application thereof |
| 08/28/2013 | CN103265626A HPV16L1-f protein and coding gene and application thereof |
| 08/28/2013 | CN103265625A HPV16L1-h protein and coding gene and application thereof |
| 08/28/2013 | CN103265624A Method for preparing copaxone |
| 08/28/2013 | CN103265623A Polypeptide having protection effect on cerebral ischemic injuries, and its application |
| 08/28/2013 | CN103265440A Method of detecting content of phenylethanolamine A and detection kit |
| 08/28/2013 | CN102766199B Single-strand deoxyribonucleic acid (ssDNA) binding protein derived from thermus TC16 and polynucleotide for coding protein |
| 08/28/2013 | CN102757970B Eucalyptus PGEF12 gene as well as plant expression vector thereof, host cell thereof and application thereof |
| 08/28/2013 | CN102643827B 4*Tbeta4 gene and method for expressing 4*Tbeta 4 protein in tobaccos |
| 08/28/2013 | CN102584981B Mutant of interferon alpha and polyethylene glycol derivatives of mutant |
| 08/28/2013 | CN102559691B Silkworm sex chromosome linked gene PdpI and recessive lethal mutation gene thereof and application of silkworm sex chromosome linked gene PdpI and recessive lethal mutation gene in silkworm sex ratio control |
| 08/28/2013 | CN102558337B Interferon alpha mutant and polyethylene glycol derivative thereof |
| 08/28/2013 | CN102485896B Regulatory gene OsNAC2 of grain number of rice panicle, its expression system and application |
| 08/28/2013 | CN102397535B Insulin crystal microsphere, insulin crystal microsphere suspension, and preparation method thereof |
| 08/28/2013 | CN102250914B Protein for treating ocular vascular proliferation |
| 08/28/2013 | CN102245759B Technique for regulating regeneration of tissue or faulty or abnormal part in organ using NELL-1 |
| 08/28/2013 | CN102219849B Method for separating and purifying exenatide on large scale |
| 08/28/2013 | CN102206251B Acyl carrier protein III epitope, acyl carrier protein III antibody and use thereof |
| 08/28/2013 | CN102140473B Anti-tumor nucleic acid and polypeptide and application thereof |
| 08/28/2013 | CN101935665B Preparation method and application of recombinant protein A gene and expression product thereof |
| 08/28/2013 | CN101906148B Survivin-derived peptides and use thereof |
| 08/28/2013 | CN101522707B 肌肉生长抑制素拮抗剂 Myostatin antagonists |
| 08/28/2013 | CN101194017B Conjugate comprising P21 protein for the treatment of cancer |
| 08/28/2013 | CN101119745B Lectin compositions and methods for modulating an immune response to an antigen |
| 08/27/2013 | US8519226 Increased stress tolerance, yield, and quality via glutaredoxin overexpression |
| 08/27/2013 | US8519222 Modification of flavonoid biosynthesis in plants |
| 08/27/2013 | US8519111 Nucleic acid and amino acid sequences encoding high-level expressor factor VIII polypeptides and methods of use |
| 08/27/2013 | US8519109 Tumour rejection antigens |
| 08/27/2013 | US8519108 Method for preparing antigen effective for preventing anthrax infection |
| 08/27/2013 | US8519103 Factor VII polypeptides that are modified and uses thereof |
| 08/27/2013 | US8519100 Non-naturally occurring T cell receptors |
| 08/27/2013 | US8519099 Methods for production of proteins |
| 08/27/2013 | US8518890 Luteinizing hormone-releasing hormone receptor agonist leuprorelin, or antagonist with androgen receptor agonist for prophylaxis, treatment of prostate cancer; dehydroepiandrosterone, testosterone, dihydrotestosterone; non-steroidal androgen receptor agonist; estradiol, estrone, estriol, stilbestrol |
| 08/27/2013 | US8518884 Methods for treating atrial or ventricular arrhythmias by administering a G-protein alpha inhibitor |
| 08/27/2013 | US8518883 Method of reducing deleterious effects of ischemia by administration of a thrombopoietin receptor ligand |
| 08/27/2013 | US8518881 Methods for inducing superovulation in ungulates |
| 08/27/2013 | US8518878 Method for treating skin aging by administration of bFGF |
| 08/27/2013 | US8518876 Composition for long-acting peptide analogs |
| 08/27/2013 | US8518871 Skin permeating and cell entering (SPACE) peptides and methods of use thereof |
| 08/27/2013 | US8518869 Pharmaceutical combined preparation containing a therapeutic protein |
| 08/27/2013 | US8518695 Compositions comprising polynucleotides encoding RDCVF1 or RDCVF2 |
| 08/27/2013 | US8518655 Means for the diagnosis and therapy of CTCL |
| 08/27/2013 | US8518436 Engineered extracellular matrices |
| 08/27/2013 | US8518412 Partial peptide of lacritin |
| 08/27/2013 | US8518411 Modified TGF-β superfamily protein |
| 08/27/2013 | US8518389 Methods of inhibiting proliferation or immunoglobulin production of B cells using human tumor necrosis factor receptor TR-17 polypeptides |
| 08/27/2013 | US8518105 Methods and apparatuses for coating a lesion |
| 08/27/2013 | CA2603814C Solid phase immobilization of phospholipids and cofactor proteins via covalent attachment |
| 08/27/2013 | CA2592894C Improved grain quality through altered expression of gamma-zein protein |
| 08/27/2013 | CA2568015C Influenza hemagglutinin and neuraminidase variants |
| 08/27/2013 | CA2558371C Methods of modulating immune responses by modulating tim-1 and tim-4 function |
| 08/27/2013 | CA2546326C Novel agents for the prevention of leishmaniosis |
| 08/27/2013 | CA2516163C High viscosity xanthan polymer preparations |
| 08/27/2013 | CA2508773C Canine rankl and methods for preparing and using the same |
| 08/27/2013 | CA2506855C Mntf peptides and compositions and methods of use |
| 08/27/2013 | CA2492099C Improved transporters and their uses |
| 08/27/2013 | CA2486918C Novel chimeric cd154 |
| 08/27/2013 | CA2291861C Zinc finger protein derivatives and methods therefor |
| 08/27/2013 | CA2227301C Hcv binding protein |
| 08/22/2013 | WO2013123412A1 Conformation-stabilized trap antigens |
| 08/22/2013 | WO2013123248A1 MODULATION OF FACTOR Xa INHIBITOR MEDIATED BLOOD LOSS BY PARTIAL AND TRANSIENT ADMINISTRATION OF ANTIDOTE |
| 08/22/2013 | WO2013123193A1 Pyruvate kinase m2 neutralizing antibodies for inhibiting angiogenesis |
| 08/22/2013 | WO2013122827A1 Computationally optimized broadly reactive antigens for human and avian h5n1 influenza |
| 08/22/2013 | WO2013122720A2 Engineered pesticidal proteins |
| 08/22/2013 | WO2013122617A1 Factor viii compositions and methods of making and using same |
| 08/22/2013 | WO2013122262A1 Virus like particle composition |
| 08/22/2013 | WO2013121428A1 ANTAGONISTS OF Bcl-2 AND USES THEREOF IN INDUCTION OF APOPTOSIS |
| 08/22/2013 | WO2013121416A1 Long-acting coagulation factors and methods of producing same |
| 08/22/2013 | WO2013121405A1 Oral unit dosage forms and uses of same for the treatment of gaucher disease |
| 08/22/2013 | WO2013121296A1 Erythrocyte-binding therapeutics |
| 08/22/2013 | WO2013120959A1 Angiostatin chimeras and uses thereof |
| 08/22/2013 | WO2013120939A1 Von willebrand factor variants having improved factor viii binding affinity |